To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

January 21, 2019

Today's Rundown

Featured Story

Novo Holdings' antibiotic resistance fund backs 3 biotechs

Novo Holdings’ REPAIR Impact Fund has revealed investments in three antibiotic resistance startups. The investments funneled around $16 million (€14 million) of the fund’s $165 million budget into the startups to support research into antibiotics and prophylactic vaccines.  

Top Stories

Immunocore lifer leaves to head research at TCR rival Scancell

Samantha Paston has ended her long association with Immunocore to take up the head of research position at Scancell. Paston’s appointment is part of a broader effort by Scancell to add experience as it steps up its immunotherapy development activities. 

Redx cleared to start Wnt cancer trial again after safety scare

Redx was hit hard last year when it was forced to suspend a phase 1/2a trial of its porcupine inhibitor for solid tumors, but it’s now been given the OK to restart testing.

GlaxoSmithKline Chairman Philip Hampton bows out as company preps for split-up

Philip Hampton joined GlaxoSmithKline as chairman just as it upped the ante in consumer health with a Novartis joint venture. Now, he's leaving, just as GSK is beefing up the unit in preparation for a company split-up.

Enrollment Showcase

Online Graduate Programs Designed for Your Career

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.

Resources

[Whitepaper] Better Market Intelligence With Smart Search

It’s never been more challenging to stay on top of competitive factors impacting your industry. Discover how AI can help competitive teams achieve more proactive market intelligence.

[POCKET GUIDE] 3 Steps To Supercharge Your Literature Search

Go from Search to Full-Text Scientific Papers in a Single Click!

[Whitepaper] Achieving launch excellence in the challenging healthcare markets of today

This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets.

[Whitepaper] Accelerate Time To Market Working With Industry Specialist MSP

With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market.

[Whitepaper] Liquid Biopsy Investor Toolkit

With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners.

[Survey] Veeva 2019 Unified Clinical Operations Survey

Share your thoughts on the life sciences industry's progress in improving study execution.

[Whitepaper] The 3DP Revolution: Planning Effective Brand Extension for In-Market Drugs

Get ahead of looming challenges in the market that include both generic products and new branded drugs.

[Infographic] Clinical Development Trends And The Impact On Clinical Trial Technology

New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM).

[Webinar] Building the Business Case for Transformational RIM

Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar.

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

Events